New York State Assembly

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 

A01910 Summary:

A01910 Actions:

A01910 Committee Votes:

A01910 Floor Votes:

A01910 Text:

 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         1910--B
 
                               2015-2016 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 13, 2015
                                       ___________
 
        Introduced by M. of A. ZEBROWSKI, CUSICK, ORTIZ, GALEF, COLTON, RUSSELL,
          BRINDISI,  JAFFEE, TITUS, ROBINSON, GUNTHER, COOK, TITONE, MAGNARELLI,
          BARRETT, STIRPE, BUCHWALD, LOPEZ, MOSLEY -- Multi-Sponsored by  --  M.
          of  A.    BARCLAY,  CERETTO,  CROUCH, DINOWITZ, DUPREY, FINCH, HAWLEY,
          MAGEE, McKEVITT, MONTESANO, PALMESANO, PEOPLES-STOKES,  PERRY,  RODRI-
          GUEZ,  STECK  --  read once and referred to the Committee on Health --
          committee discharged, bill amended, ordered reprinted as  amended  and
          recommitted  to  said  committee -- again reported from said committee
          with amendments, ordered reprinted as amended and recommitted to  said
          committee
 
        AN  ACT to amend the public health law, in relation to adding cannabimi-
          metic agents to the schedule of controlled substances
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Schedule  I  of  section 3306 of the public health law is
     2  amended by adding a new subdivision (g) to read as follows:
     3    (g) (1) Cannabimimetic agents. Unless specifically exempted or  unless
     4  listed in another schedule, any material, compound, mixture, or prepara-
     5  tion  that  is  not approved by the federal food and drug administration
     6  (FDA) which contains any quantity of  cannabimimetic  agents,  or  which
     7  contains  their salts, isomers, and salts of isomers whenever the exist-
     8  ence of such salts, isomers, and salts of isomers is possible within the
     9  specific chemical designation.
    10    (2) As used in this  subdivision,  the  term  "cannabimimetic  agents"
    11  means any substance that is a cannabinoid receptor type 1 (CB1 receptor)
    12  agonist  as demonstrated by binding studies and functional assays within
    13  any of the following structural classes:
    14    (i) 2-(3-hydroxycyclohexyl)phenol with substitution at the  5-position
    15  of  the phenolic ring by alkyl or alkenyl, whether or not substituted on
    16  the cyclohexyl ring to any extent.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00526-03-5
        A. 1910--B                          2
 
     1    (ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole  by  substi-
     2  tution  at  the nitrogen atom of the indole ring, whether or not further
     3  substituted on the indole ring to any extent, whether or not substituted
     4  on the naphthoyl or naphthyl ring to any extent.
     5    (iii)  3-(1-naphthoyl)pyrrole  by substitution at the nitrogen atom of
     6  the pyrrole ring, whether or not further substituted in the pyrrole ring
     7  to any extent, whether or not substituted on the naphthoyl ring  to  any
     8  extent.
     9    (iv)  1-(1-naphthylmethylene)indene  by substitution of the 3-position
    10  of the indene ring, whether or not further  substituted  in  the  indene
    11  ring  to  any extent, whether or not substituted on the naphthyl ring to
    12  any extent.
    13    (v) 3-phenylacetylindole or 3-benzoylindole  by  substitution  at  the
    14  nitrogen  atom of the indole ring, whether or not further substituted in
    15  the indole ring to any extent, whether or not substituted on the  phenyl
    16  ring to any extent.
    17    (3) Such term includes:
    18    (i)      5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol
    19  (CP-47,497);
    20    (ii)      5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol
    21  (cannabicyclohexanol or CP-47,497 C8-homolog);
    22    (iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);
    23    (iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);
    24    (v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);
    25    (vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);
    26    (vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
    27    (viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);
    28    (ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
    29    (x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
    30    (xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
    31    (xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
    32    (xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);
    33    (xiv)   1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole  (SR-18  and
    34  RCS-8); and
    35    (xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).
    36    § 2. This act shall take effect on the ninetieth day  after  it  shall
    37  have become a law.